Navigation Links
Data on Avicena's Drug Candidate HD-02 Presented at the 2007 World Congress on Huntington's Disease
Date:11/19/2007

se III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

SAFE HARBOR

This release contains forward-looking statements that reflect, among other things, management's current expectations, plans and strategies, all of which are subject to known and unknown risks, uncertainties and factors that may cause our actual results to differ materially from those expressed or implied by these forward-looking statements. Many of these risks are beyond our ability to control or predict. See "Risk Factors" under "Item 6. Management's Discussion and Analysis of Financial Condition and Results of Operation" from our Annual Report on Form 10-KSB for the year ended December 31, 2006, and other descriptions in the Company's public filings with the Securities and Exchange Commission for a discussion of such risks, including the Company's need for additional funds, the Company's dependence on a limited number of therapeutic compounds, the stage of the products the Company is developing, uncertainties relating to clinical trials and regulatory reviews, competition and dependence on collaborative partners, the Company's ability to avoid infringement of the patent rights of others, and the Company's ability to obtain adequate patent protection and to enforce these rights. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Avicena does not undertake any obligation to update or review any such forward-looking information, whether as a result of new information, future events or otherwise.

Contact:

The R
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Some Epilepsy Patients Are Good Candidates for Surgery
2. Presidential Candidates Address Health, Financial Security at AARPs Life@50+
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. U.S. Physicians Question Presidential Candidates
5. Schizophrenia candidate genes affect even healthy individuals
6. Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement
7. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
8. Poll Shows Voters Want Long Term Care Included in Presidential Candidates Healthcare Proposals, Released at 2007 National Long Term Care Symposium
9. 1 in 5 bariatric surgery candidates not psychologically cleared for surgery
10. Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates
11. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... External Counterpulsation (EECP/ECP) has been used ... United States. There are a growing number of people ... symptoms of angina and these patients are often times ... surgery. , “No option” patients are a sizable cohort ... that is considered unacceptable for heart stent or bypass. ...
(Date:5/28/2015)... The USC Verdugo Hills Hospital Wound Care program has ... with a current average healing rate of 35 days. In ... Advantage to provide in-patient wound care. This month the WCA ... the rate of hospital-acquired pressure ulcers from 14 percent to ... that can frighten patients and caregivers who are just learning ...
(Date:5/28/2015)... 28, 2015 Technology public relations ... (CNCK) as its agency of record to support ... app, SugarChecked. SugarChecked is an everyday grocery-shopping tool ... potential sugars they are putting in their bodies. ... of SugarChecked, execute media initiatives following launch, lead ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will ... honor the strength, passion and endurance of those facing ... of this sunrise-to-sunset event symbolizes the challenging journey of ... raise funds and awareness to advance the care, support ... are encouraged to create their own experience as they ...
(Date:5/28/2015)... Township, NJ (PRWEB) May 28, 2015 The ... gift of $2,500 from Horizon Blue Cross Blue Shield of ... pro golfer Natalie Gulbis, the club can receive much more ... Presented by Acer. , A former Boys & Girls Club ... up in Sacramento, California, Ms. Gulbis has accepted the Horizon ...
Breaking Medicine News(10 mins):Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3
... Inappropriate activation of a single enzyme, telomerase, is associated ... many as 90 percent of all of human cancers. ... human tumors, scientists have eyed the enzyme as an ... , Now, researchers working at The Wistar Institute have ...
... N.C. New research from Wake Forest University Baptist ... barrier to receiving a kidney transplant and that ... may help alleviate the burgeoning organ shortage among older ... been a considered a barrier for both organ donation ...
... For the millions of Americans whose native tongue ... quality healthcare, according to a University of California, Irvine ... Research in the UC Irvine School of Medicine have ... result in longer hospital stays, more medical errors and ...
... -,- Higher Percentage of Physicians, Nurses Take Supplements ... The landmark "Life...supplemented",Healthcare Professionals (HCP) Impact Study found ... percent) and nurses (82 percent) recommend,dietary supplements to ... almost,equal number -- 72 percent of physicians and ...
... VA Continuing Diabetes Education Drive, WASHINGTON, Nov. 13 ... today the Department of Veterans,Affairs (VA) plans to expand ... an ongoing campaign to help veterans eat healthy, watch ... percent of VA patients living with diabetes, it is,important ...
... , Researchers at the University of Granada ( UGR ) ... of the Hospital Clnico San Cecilio in Granada ... the earliest diagnosis of pulmonary hypertension possible, which is the ... rare disease which affects approximately 1,200 out of every million ...
Cached Medicine News:Health News:Telomerase enzyme structure provides significant new target for anti-cancer therapies 2Health News:Telomerase enzyme structure provides significant new target for anti-cancer therapies 3Health News:Higher-risk kidneys may help solve organ shortage facing older adults 2Health News:Higher-risk kidneys may help solve organ shortage facing older adults 3Health News:Language barriers adversely impact health-care quality 2Health News:Study Finds Physicians and Nurses Both Take and Recommend Dietary Supplements 2Health News:Study Finds Physicians and Nurses Both Take and Recommend Dietary Supplements 3Health News:Study Finds Physicians and Nurses Both Take and Recommend Dietary Supplements 4Health News:Study Finds Physicians and Nurses Both Take and Recommend Dietary Supplements 5Health News:Watch Your Weight, Keep Up Physical Activity 2Health News:A new method allows for the early diagnosis of pulmonary hypertension 2Health News:A new method allows for the early diagnosis of pulmonary hypertension 3
(Date:5/28/2015)... Mass., May 28, 2015  Shareholder rights law ... whether certain officers and directors of Eleven Biotherapeutics, ... Eleven Biotherapeutics is a clinical-stage biopharmaceutical company that ... therapeutics to treat eye diseases, primarily in ... View this press release on the law ...
(Date:5/28/2015)... 28, 2015   Eli Lilly and Company (NYSE: ... host a webcast on June 11 to discuss data from ... rheumatoid arthritis. Data from these two trials, RA-BEACON and RA-BUILD, will ... the EULAR Congress 2015 in Rome, Italy ... to11:00 a.m. Eastern Daylight Time. The live audio webcast can ...
(Date:5/28/2015)... ROCKLAND, Mass. , May 28, 2015 /PRNewswire/ ... a leading company for innovative and top-quality high-tech ... today announced a global collaboration agreement with the ... dedicated to advancing fertility science and helping couples ... Germany , a global market ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 2Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 3Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx 4
... SuccessEHS, a nationally recognized, streamlined practice management and ... recently named by the Arkansas Regional Extension Center (REC) ... health care initiatives. Regional Extension ... endowed by the Office of the National Coordinator for ...
... 17, 2011 ORTHOCON, Inc., a developer of implantable products ... to bone, today announced the U.S. launch of its first ... The HEMA SORB Absorbable Bone Hemostat ... absorbable putty that is designed to rapidly stop bleeding when ...
Cached Medicine Technology:Arkansas REC Selects SuccessEHS as Preferred Vendor 2Arkansas REC Selects SuccessEHS as Preferred Vendor 3ORTHOCON® Announces U.S. Market Launch of HEMASORB® 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: